StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)

Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –

AtriCure cash

Cash and short-term investments held at the end of each period.

AtriCure's cash was $167.79M at Jun 30, 2026. For fiscal 2025 it was $167.43M, up 36.4% from the year before. Over ten years it grew 17.1% a year on average. The highest annual figure on record is $244.22M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$167.43M+36.4%
FY2024Dec 31, 2024$122.72M-10.6%
FY2023Dec 31, 2023$137.29M+13.4%
FY2022Dec 31, 2022$121.11M+1.7%
FY2021Dec 31, 2021$119.09M-51.2%
FY2020Dec 31, 2020$244.22M+198.6%
FY2019Dec 31, 2019$81.80M-34.2%
FY2018Dec 31, 2018$124.40M+261.1%
FY2017Dec 31, 2017$34.45M-21.7%
FY2016Dec 31, 2016$44.01M+27.3%
FY2015Dec 31, 2015$34.58M-42.0%
FY2014Dec 31, 2014$59.65M+127.6%
FY2013Dec 31, 2013$26.21M+118.4%
FY2012Dec 31, 2012$12.00M-15.4%
FY2011Dec 31, 2011$14.18M+12.8%
FY2010Dec 31, 2010$12.57M+41.2%
FY2009Dec 31, 2009$8.91M-22.2%
FY2008Dec 31, 2008$11.45M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$167.79M+42.4%
Q1 FY2026Mar 31, 2026$146.17M+46.3%
Q4 FY2025Dec 31, 2025$167.43M+36.4%
Q3 FY2025Sep 30, 2025$147.87M+13.4%
Q2 FY2025Jun 30, 2025$117.80M+3.3%
Q1 FY2025Mar 31, 2025$99.89M-5.7%
Q4 FY2024Dec 31, 2024$122.72M-10.6%
Q3 FY2024Sep 30, 2024$130.34M-2.0%
Q2 FY2024Jun 30, 2024$114.02M-10.2%
Q1 FY2024Mar 31, 2024$105.96M-22.0%
Q4 FY2023Dec 31, 2023$137.29M+13.4%
Q3 FY2023Sep 30, 2023$133.01M+8.5%
Q2 FY2023Jun 30, 2023$127.03M+7.2%
Q1 FY2023Mar 31, 2023$135.86M+22.0%
Q4 FY2022Dec 31, 2022$121.11M+1.7%
Q3 FY2022Sep 30, 2022$122.64M+2.4%
Q2 FY2022Jun 30, 2022$118.45M-25.9%
Q1 FY2022Mar 31, 2022$111.40M-51.0%
Q4 FY2021Dec 31, 2021$119.09M-51.2%
Q3 FY2021Sep 30, 2021$119.75M-48.6%
Q2 FY2021Jun 30, 2021$159.87M-31.2%
Q1 FY2021Mar 31, 2021$227.21M+231.5%
Q4 FY2020Dec 31, 2020$244.22M+198.6%
Q3 FY2020Sep 30, 2020$233.07M+192.3%
Q2 FY2020Jun 30, 2020$232.50M+155.9%
Q1 FY2020Mar 31, 2020$68.54M-31.9%
Q4 FY2019Dec 31, 2019$81.80M-34.2%
Q3 FY2019Sep 30, 2019$79.74M+98.3%
Q2 FY2019Jun 30, 2019$90.84M+145.1%
Q1 FY2019Mar 31, 2019$100.63M+179.2%
Q4 FY2018Dec 31, 2018$124.40M+261.1%
Q3 FY2018Sep 30, 2018$40.22M+17.0%
Q2 FY2018Jun 30, 2018$37.07M+6.0%
Q1 FY2018Mar 31, 2018$36.04M+4.6%
Q4 FY2017Dec 31, 2017$34.45M-21.7%
Q3 FY2017Sep 30, 2017$34.39M-16.8%
Q2 FY2017Jun 30, 2017$34.98M–
Q1 FY2017Mar 31, 2017$34.47M–
Q4 FY2016Dec 31, 2016$44.01M–
Q3 FY2016Sep 30, 2016$41.34M–

More AtriCure figures

See a number that looks wrong?